Literature DB >> 23404120

Long-term blood pressure and age-related macular degeneration: the ALIENOR study.

Audrey Cougnard-Grégoire1, Marie-Noëlle Delyfer, Jean-François Korobelnik, Marie-Bénédicte Rougier, Florence Malet, Mélanie Le Goff, Jean-François Dartigues, Joseph Colin, Pascale Barberger-Gateau, Cécile Delcourt.   

Abstract

PURPOSE: To explore the association of AMD with long-term average blood pressure (BP) parameters, including pulse pressure (PP).
METHODS: The ALIENOR study is a population-based study on age-related eye diseases in 963 residents of Bordeaux, France, aged 73 years or older. AMD was graded from nonmydriatic color retinal photographs, in three exclusive stages: no AMD (1015 eyes), large soft distinct drusen and/or large soft indistinct drusen and/or reticular drusen and/or pigmentary abnormalities (early AMD, 276 eyes), and late AMD (66 eyes). BP parameters were measured at four occasions over a 7-year period. PP was defined as systolic BP minus diastolic BP. Associations of AMD with BP parameters were estimated using generalized estimating equation logistic regressions. Statistical analyses included 702 subjects (1357 eyes) with complete data.
RESULTS: After adjustment for age, sex, educational level, smoking, body mass index, plasma HDL and LDL cholesterol, CFH Y402H, ApoE2, ApoE4, and ARMS2 A69S polymorphisms, elevated PP was significantly associated with an increased risk of late AMD (odds ratio [OR] = 1.37 for a 10-mm Hg increase, 95% confidence interval [CI]: 1.03-1.82). Associations were similar for late atrophic and late neovascular AMD (OR = 1.39, 95% CI: 1.01-1.92, P = 0.04, and OR = 1.43, 95% CI: 0.90-2.23, P = 0.13, respectively). Association with early AMD was in the same direction but did not reach statistical significance (OR = 1.12, 95% CI: 0.98-1.28). Early and late AMD were not significantly associated with systolic or diastolic BP, hypertension, or use of antihypertensive medications.
CONCLUSIONS: This study suggests that high PP may be associated with increased risk for AMD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404120     DOI: 10.1167/iovs.12-10192

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Incidence of and Risk Factors Associated With Age-Related Macular Degeneration: Four-Year Follow-up From the ALIENOR Study.

Authors:  Valentine Saunier; Bénédicte M J Merle; Marie-Noëlle Delyfer; Audrey Cougnard-Grégoire; Marie-Bénédicte Rougier; Philippe Amouyel; Jean-Charles Lambert; Jean-François Dartigues; Jean-François Korobelnik; Cécile Delcourt
Journal:  JAMA Ophthalmol       Date:  2018-05-01       Impact factor: 7.389

2.  A Drug-Tunable Gene Therapy for Broad-Spectrum Protection against Retinal Degeneration.

Authors:  Clayton P Santiago; Casey J Keuthan; Sanford L Boye; Shannon E Boye; Aisha A Imam; John D Ash
Journal:  Mol Ther       Date:  2018-07-19       Impact factor: 11.454

3.  No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.

Authors:  Emily Y Chew; Michael L Klein; Traci E Clemons; Elvira Agrón; Rinki Ratnapriya; Albert O Edwards; Lars G Fritsche; Anand Swaroop; Gonçalo R Abecasis
Journal:  Ophthalmology       Date:  2014-06-26       Impact factor: 12.079

Review 4.  Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.

Authors:  Katie L Pennington; Margaret M DeAngelis
Journal:  Eye Vis (Lond)       Date:  2016-12-22

5.  Nutritional Supplementation Inhibits the Increase in Serum Malondialdehyde in Patients with Wet Age-Related Macular Degeneration.

Authors:  Toshiyuki Matsuura; Kei Takayama; Hiroki Kaneko; Fuxiang Ye; Hiroshi Fukukita; Taichi Tsunekawa; Keiko Kataoka; Shiang-Jyi Hwang; Yosuke Nagasaka; Yasuki Ito; Hiroko Terasaki
Journal:  Oxid Med Cell Longev       Date:  2017-01-24       Impact factor: 6.543

6.  AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration.

Authors:  Ki-Hong Jang; Yun-Ju Do; Dongwon Son; Eunji Son; Jun-Sub Choi; Eunhee Kim
Journal:  Cell Death Dis       Date:  2017-01-05       Impact factor: 8.469

7.  Chemokine Profile and the Alterations in CCR5-CCL5 Axis in Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Authors:  Marie Krogh Nielsen; Yousif Subhi; Christopher Rue Molbech; Mads Krüger Falk; Mogens Holst Nissen; Torben Lykke Sørensen
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-04-09       Impact factor: 4.799

Review 8.  Age-Related Macular Degeneration: What Do We Know So Far?

Authors:  Ho Hin Ma; Rasa Liutkevičienė
Journal:  Acta Med Litu       Date:  2021-01-18

Review 9.  Recent developments in age-related macular degeneration: a review.

Authors:  Waseem M Al-Zamil; Sanaa A Yassin
Journal:  Clin Interv Aging       Date:  2017-08-22       Impact factor: 4.458

Review 10.  Novel Programmed Cell Death as Therapeutic Targets in Age-Related Macular Degeneration?

Authors:  Ming Yang; Kwok-Fai So; Wai Ching Lam; Amy Cheuk Yin Lo
Journal:  Int J Mol Sci       Date:  2020-10-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.